Lotfi Benboubker
Université de Tours(FR)Centre Hospitalier Universitaire de Tours(FR)
Publications by Year
Research Areas
Multiple Myeloma Research and Treatments, Protein Degradation and Inhibitors, Peptidase Inhibition and Analysis, Cancer Treatment and Pharmacology, Chronic Lymphocytic Leukemia Research
Most-Cited Works
- → Teclistamab in Relapsed or Refractory Multiple Myeloma(2022)1,022 cited
- → Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study(2019)936 cited
- → Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myelome(2007)900 cited
- → Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99–06): a randomised trial(2007)870 cited
- → Lenalidomide and Dexamethasone in Transplant-Ineligible Patients with Myeloma(2014)782 cited
- → Maintenance therapy with thalidomide improves survival in patients with multiple myeloma